TM4SF4 and cancer: Additionally, Hz2B7-1.2 induced robust ADCC in MIA PaCa-2 (pancreatic cancer) and Huh7 (hepatocellular carcinoma) (Figure 7B), but not in THLE-2 (normal liver cells), confirming its specificity for TM4SF4-expressing cancer cells (Figure S3).